SHANNON LUCAS: Open Payments
NPI 1790756898 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,270 in 65 payments from 17 companies in 2025. Trend: 2023 $1,349 · 2024 $970 · 2025 $1,270
Food & beverage: $1,270
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $196 |
| Novartis Pharmaceuticals Corporation | 13 | $154 |
| AstraZeneca Pharmaceuticals LP | 8 | $148 |
| Kestra Medical Technology Services, Inc. | 4 | $143 |
| PFIZER INC. | 6 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $101 |
| Merck Sharp & Dohme LLC | 4 | $93 |
| Actelion Pharmaceuticals US, Inc. | 2 | $54 |
| Amgen Inc. | 3 | $54 |
| Boston Scientific Corporation | 2 | $48 |
Products named: ELIQUIS, Assure WCD, LEQVIO, CAMZYOS, JARDIANCE, VERQUVO, OPSUMIT, General - EP.
Industry payments across TX — which companies pay providers there.
